Axon Enterprise ( NASDAQ:AXON – Free Report ) had its target price reduced by Barclays from $256.00 to $239.00 in a research report released on Wednesday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company's stock. A number of other equities research analysts also recently weighed in on AXON. TheStreet downgraded Axon Enterprise from a b- rating to a c+ rating in a report on Friday, May 26th. Credit Suisse Group lifted their target price on Axon Enterprise from $300.

https://www.dailypolitical.com/2023/08/13/barclays-trims-axon-enterprise-nasdaqaxon-target-price-to-239-00.html

#dailypolitical